An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry

J Lipid Res. 2005 Feb;46(2):373-82. doi: 10.1194/jlr.D400029-JLR200. Epub 2004 Nov 1.

Abstract

We describe an improved assay for platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) using HPLC-tandem mass spectrometry (LC-MS/MS). The present method can readily detect as little as 1 pg (1.9 fmol) of PAF, a significant improvement over previously described LC-MS/MS methods, and gives a linear response up to 1,000 pg of PAF. Our method also overcomes the artifacts from isobaric lipids that have limited the usefulness of certain existing LC-MS/MS assays for PAF. In the course of these studies, we detected three novel lipid species in human neutrophils. One of the novel lipids appears to be a new molecular species of PAF, and the other two have chromatographic and mass spectrometric properties consistent with stearoyl-formyl-glycerophosphocholine and oleoyl-formyl-glycerophosphocholine. These observations identify previously unknown potential interferences in the measurement of PAF by LC-MS/MS. Moreover, our data suggest that the previously described palmitoyl-formyl-glycerophosphocholine is not unique but rather is a member of a new and poorly understood family of formylated lipids.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Catalysis
  • Chromatography
  • Chromatography, High Pressure Liquid / methods*
  • Clinical Chemistry Tests*
  • Glycerophospholipids / metabolism
  • Humans
  • Lipid Metabolism
  • Lipids / chemistry
  • Lysophosphatidylcholines / chemistry
  • Mass Spectrometry / methods*
  • Neutrophils / metabolism
  • Platelet Activating Factor / biosynthesis*
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Glycerophospholipids
  • Lipids
  • Lysophosphatidylcholines
  • Platelet Activating Factor